PepGen · 3 days ago
Staff Accountant
PepGen is a clinical-stage biotechnology company focused on advancing oligonucleotide therapies for severe neuromuscular and neurological diseases. The Staff Accountant will play a crucial role in enhancing the accounting and finance organization, managing accounts payable processes, vendor communications, and monthly reconciliations.
BiotechnologyClinical TrialsMedical
Responsibilities
Perform daily accounts payable tasks, which include accounts payable inbox management, invoice input, and vendor inquiry responses
Prepare weekly payment runs and internal transfer requests
Assist with the month end close process
Complete monthly cash and accounts payable reconciliations
Perform monthly credit card reconciliation
Input journal entries in general ledger system, which includes the preparation and submission of supporting documentation and work papers
Ensure timely and complete delivery of any documentation required to support external and internal audits and reporting
Monitor and participate in and enhance formal processes for internal controls surrounding the reporting process to ensure compliance with Sarbanes Oxley Act requirements
Manage vendor maintenance within procurement system
Additional assignments as assigned by the Management
Qualification
Required
A Bachelor's Degree in Accounting
Knowledge of U.S. GAAP
Excellent communication skills, both written and verbal with the ability to work with all levels of management and employees
Effective time management skills with a focus on process improvement
Organized and able to manage multiple activities and programs timely and with a high degree of accuracy
Must be able to work under deadline pressure and willingness to meet critical deadlines
Ability to deal sensitively with confidential material
Benefits
Discretionary annual bonus
Equity
Health insurance (including medical, dental, and vision)
Life and disability insurance
Paid time off with paid holidays
Paid parental leave
A 401(k) plan
Cell phone reimbursement
Student loan repayment or 529 contributions
Lifestyle spending account
Company
PepGen
PepGen is empowering nucleic acid therapeutics to go the distance.
Funding
Current Stage
Public CompanyTotal Funding
$354.68MKey Investors
RA Capital Management
2025-09-24Post Ipo Equity· $115M
2024-02-07Post Ipo Equity· $80.1M
2022-05-06IPO
Recent News
2025-12-09
2025-12-08
Company data provided by crunchbase